Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.37 | 0.08 | 0.08 | -1.98 |
| FCF Yield | 0.91% | 2.55% | 0.81% | 1.44% |
| EV / EBITDA | 57.83 | 26.50 | 86.70 | 62.57 |
| Quality | ||||
| ROIC | 9.97% | -13.01% | 7.53% | 2.68% |
| Gross Margin | 63.40% | 41.41% | 61.89% | 59.45% |
| Cash Conversion Ratio | 1.15 | – | 1.52 | 10.79 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.59% | 7.36% | 9.79% | 13.64% |
| Free Cash Flow Growth | -74.81% | 130.40% | -12.17% | 285.04% |
| Safety | ||||
| Net Debt / EBITDA | -0.42 | -0.17 | 0.12 | 0.43 |
| Interest Coverage | 54.22 | -33.42 | 68.16 | 10.57 |
| Efficiency | ||||
| Inventory Turnover | 1.20 | 2.19 | 1.09 | 1.19 |
| Cash Conversion Cycle | 42.54 | 56.21 | 49.82 | 92.72 |